Short interfering RNA as an antiviral agent for Hepatitis C

Details for Australian Patent Application No. 2004261936 (hide)

Owner Amgen Inc

Inventors Jayasena, Sumedha; Richardson, Christopher Donald

Agent Shelston IP

Pub. Number AU-A-2004261936

PCT Pub. Number WO2005/012525

Priority 60/490,204 25.07.03 US; 10/897,648 22.07.04 US

Filing date 23 July 2004

Wipo publication date 10 February 2005

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/012525 Priority application(s): WO2005/012525

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261941-Antagonists and agonists of LDCAM and methods of use

2004261901-Additive for ship bottom paint and ship bottom paint comprising the same